| 000 | 01806 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514073941.0 | ||
| 264 | 0 | _c20040105 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 024 | 7 |
_a10.1182/blood-2003-03-0703 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSprong, Tom | |
| 245 | 0 | 0 |
_aInhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis. _h[electronic resource] |
| 260 |
_bBlood _cNov 2003 |
||
| 300 |
_a3702-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aBlood _xmicrobiology |
| 650 | 0 | 4 |
_aComplement Activation _xdrug effects |
| 650 | 0 | 4 |
_aComplement C5a _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aComplement Membrane Attack Complex _ximmunology |
| 650 | 0 | 4 |
_aGranulocytes _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 |
_aMacrophage-1 Antigen _xbiosynthesis |
| 650 | 0 | 4 |
_aMeningococcal Infections _xdrug therapy |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aMonocytes _xmetabolism |
| 650 | 0 | 4 |
_aNeisseria meningitidis _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Fc _xbiosynthesis |
| 650 | 0 | 4 |
_aRespiratory Burst _xdrug effects |
| 650 | 0 | 4 |
_aSepsis _xdrug therapy |
| 700 | 1 | _aBrandtzaeg, Petter | |
| 700 | 1 | _aFung, Michael | |
| 700 | 1 | _aPharo, Anne M | |
| 700 | 1 | _aHøiby, E Arne | |
| 700 | 1 | _aMichaelsen, Terje E | |
| 700 | 1 | _aAase, Audun | |
| 700 | 1 | _avan der Meer, Jos W M | |
| 700 | 1 | _avan Deuren, Marcel | |
| 700 | 1 | _aMollnes, Tom E | |
| 773 | 0 |
_tBlood _gvol. 102 _gno. 10 _gp. 3702-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2003-03-0703 _zAvailable from publisher's website |
| 999 |
_c12658408 _d12658408 |
||